ARCHIVES

Fake Avastin, Paid for by Medicare, Administered to U.S. Patients

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Oncology Division Director Says Goal to Make Review Process “Predictable”

August 2, 1996

Reimbursement Policy By Philadelphia Blue Cross Further Explained

April 21, 1989

Symptoms Don’t Help Detect Early-Stage Ovarian Cancer

February 26, 2010

In Brief: Zelen To Retire As Head Of ECOG Statistical Center; NIH Organizes Genome Research Center

October 20, 1989

Two Avastin Trials Show OS Benefit In Advanced Disease

August 27, 2010

NCI Sets its Targets for Grant Success Rate and R01 Payline for FY05.

January 21, 2005